Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antithrombotic/antiallergic TxA2 synthase inhibitors from Terumo

July 26, 1996

D-HG: DIC/thrombosis treatment

July 26, 1996

BASF reports thrombin inhibitors

July 26, 1996

Alpha2-adrenoceptor agonists effective as cardiac arrest treatment

July 26, 1996

SR-140333 claimed as a cardioregulatory drug

July 26, 1996

BES and BENSPM claimed as vascular proliferative disorders treatment

July 26, 1996

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

Pierre Fabre reports antioxidants

July 26, 1996

Leukocyte elastase inhibitors reported by Sanofi Winthrop

July 26, 1996

Tryptase inhibitors described as immune-based inflammatory disorders treatment

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...